Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.93-0.92 (-5.15%)
At close: 04:00PM EST
16.93 0.00 (0.00%)
After hours: 06:03PM EST
Advertisement
Sign in to post a message.
  • R
    Richard
    This is a gift, thank you see you in January when we are over $40
  • I
    Isaiah
    would love to see $35+ by end of the month. Risking 10% downside for 30% upside.
  • Y
    Yahoo Finance Insights
    Relmada Therapeutics is down 7.04% to 19.94
  • A
    Andi V
    I am wondering what is moving this stock up in the last few days? That is the issue with such small companies and no marketing - stale website, no news. Not saying that people are not making advances but if they would care, they would ramp up the talk not just the walk.
  • E
    Edward
    VTGN is next to take off GLTA
  • E
    Edward
    Congratulations Longs 👍
  • R
    Rafet
    It is time to short this stock. It reached the top. It is overvalued.
    Bearish
  • I
    Iskender
    up and down
  • Y
    Yahoo Finance Insights
    Relmada Therapeutics is down 7.01% to 21.10
  • K
    K
    What happened over here? RLMD was low $30’s fir a year, then suddenly this massive haircut. Isn’t this a $200 to $300 stock in a two years?
  • R
    Rick
    $75 price target by Jeffries
  • Z
    Z
    So we have 13 times normal volume, up 37% and up another 6% after hours.
    Sure is a lot of buying.
    Perhaps short covering, momentum buying, mutual finds taking an interest.
    Perhaps the drug is more efficacious than thought, deals being worked out with other companies, or something else, who knows.

    Like my long position.
    Will review by DD to see if I missed anything.
  • H
    Harry
    Methadone is an off-patent drug used for pain. Rel-1017 is a pure stereo form of Methadone, no applicable compound patent.
    Bearish
  • R
    Rafet
    I checked the vector vest statistics. It is currently hold and upside potential is 0.01. Which is very unfortunate for longs. And it is overvalued . The real value is $1.74. they say timing is great, but that’s not for buying though.
    Bearish
  • Y
    Yahoo Finance Insights
    Relmada Therapeutics is up 5.92% to 24.86
  • R
    Ryan
    ANAB look at 3 month chart and max!

    A N A B keep your eyes on it, level two stacking up.

    WORK will be a moon shot later today.

    This is the one for today!
    5 to 7 market makers already stacked up and wanting all the shares of slack each can afford. ZM will do probably five or ten points higher than the coming slack move north.

    The rumor on the net is they are going to post a way smaller loss or even a small profit. Oh I hope it is true. I expected it for sure next quarter but didn't know for sure it would be this time after the bell.

    As soon as NET breaks 22 and ends up at 27 28 a couple days later hedge funds will pile in and take straight to the 40's like Data Dog from panic buying of being left out of the next hottest niche software sector. BJ wholesale club the baby costco is going to behave the same way.

    ZM ANAB DOCU GTIM WORK TSLA BYND ULTA BJ,DOMO long with ULTA NFLX puts. No deal till Nov 2020 is going to need 1 or 2 half point cuts.

    Work will go nuts today because Slack which was a direct offering IPO could beat the small loss amount or post a penny or two profit.. If they do the usual collusion by the top three or four investment banks won't be able to stop the steep spike up just to kill the calls and get more shares cheaper.

    Work (slack) has some serious setup stacking occuring on level 2. This should carry over to DOCU and ZM buying also.

    Direct offering listings if they have any positive surprise at all have serious surges after becoming way oversold first usually. Spot and it's last surge were an example of how direct offered listings are usually much easier to make money in for individual investors verse just regular ipo's screwing people out of even being able to obtain small profits.

    Docu makes the software so you can sign digitally all the major contracts for employment companies like Mcdonalds and many others are using. They are all going paperless for better record keeping and Docu has a huge lock on this lucrative area not to mention the highest % compared to most everyone else. Strongly positioned for growth and record gains for years is putting it mildly.

    Biotechs starting to heat up but man do you have to be careful, just pick anything and your calls will get changed to no bid or crushed 90%

    4 employees, interesting for rlmd.
  • D
    Donna
    Did you see the AVXL alzheimers news? read the post on ihub 222115.
  • Y
    Yahoo Finance Insights
    Relmada Therapeutics is up 6.38% to 32.12
  • Z
    Z
    Something going on here this morning, over 140K volume premarket.
  • A
    Andi V
    I sometimes feel as if the management or somebody else is propping these shares - buying periodically a little bit, just so they do not slide to 50cents or something.
Advertisement
Advertisement